OR2L13 was identified as a significantly down-regulated OR gene in GBM compared to normal and LGG tissues (Figure 1B and Table S1), with cell-type-specific expression analysis revealing its predominant expression in oligodendrocytes and neurons rather than tumor cells (Figure 2D, Figures S1B and S8). The gene discussed is OR2L13; the disease is neoplasm.